Epidemiology of subtypes of hyperthyroidism in Denmark: A population-based study

European Journal of Endocrinology

Volumn 164, Issue 5, 2011, Pages 801-809

  Carlé, Allan ^a   Pedersen, Inge Bülow ^a   Knudsen, Nils ^b   Perrild, Hans ^b   Ovesen, Lars ^c   Rasmussen, Lone Banke ^d   Laurberg, Peter ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c SLAGELSE HOSPITAL   (Denmark)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE ANTIBODY; LIOTHYRONINE; THYROID HORMONE RECEPTOR ANTIBODY; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; AMIODARONE; LITHIUM; THYROID HORMONE RECEPTOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GEOGRAPHIC DISTRIBUTION; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; INCIDENCE; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; POSTPARTUM THYROIDITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBACUTE THYROIDITIS; THYROID ADENOMA; THYROID FUNCTION TEST; THYROID SCINTISCANNING; THYROID SURGERY; THYROTOXICOSIS; TOXIC GOITER; ADOLESCENT; CHILD; CLASSIFICATION; COMPARATIVE STUDY; HEALTH SURVEY; METHODOLOGY; MIDDLE AGED; NODULAR GOITER; ANTIBODY DETECTION; MEDICAL HISTORY; SCHOOL CHILD; SEX RATIO; STANDARDIZED INCIDENCE RATIO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COHORT STUDIES; FEMALE; GOITER, NODULAR; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79955549395     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1155     Document Type: Article

References (51)

1. Canaris GJ, Manowitz NR, Mayor G & Ridgway EC. The Colorado thyroid disease prevalence study. Archives of Internal Medicine 2000 160 526-534. (doi:10.1001/archinte.160.4.526)
2. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley EJ, Hasan DM, Rodgers H & Tunbridge F. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology 1995 43 55-68. (doi:10.1111/j.1365-2265.1995.tb01894.x)
3. Laurberg P, Pedersen KM, Vestergaard H & Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. Journal of Internal Medicine 1991 229 415-420. (doi:10.1111/j.1365-2796.1991.tb00368.x)
4. Laurberg P, Bulow PI, Pedersen KM & Vestergaard H. Low incidence rate of overt hypothyroidism compared with hyperthyroidism in an area with moderately low iodine intake. Thyroid 1999 9 33-38. (doi:10.1089/thy.1999.9.33)
5. Baltisberger BL, Minder CE & Burgi H. Decrease of incidence of toxic nodular goitre in a region of Switzerland after full correction of mild iodine deficiency. European Journal of Endocrinology 1995 132 546-549. (doi:10.1530/eje.0.1320546)
6. Mostbeck A, Galvan G, Bauer P, Eber O, Atefie K, Dam K, Feichtinger H, Fritzsche H, Haydl H, Kohn H, Konig B, Koriska K, Kroiss A, Lind P, Markt B, Maschek W, Pesl H, Ramschak-Schwarzer S, Riccabona G, Stockhammer M & Zechmann W. The incidence of hyperthyroidism in Austria from 1987 to 1995 before and after an increase in salt iodization in 1990. European Journal of Nuclear Medicine 1998 25 367-374. (doi:10.1007/s002590050234)
7. Galofre JC, Garcia-Mayor RV, Fluiters E, Fernandez-Calvet L, Rego A, Paramo C & Andrade MA. Incidence of different forms of thyroid dysfunction and its degrees in an iodine sufficient area. Thyroidology 1994 6 49-54.
8. Abraham-Nordling M, Torring O, Lantz M, Hallengren B, Ohrling H, Lundell G, Calissendorff J, Jorneskog G & Wallin G. Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005. European Journal of Endocrinology 2008 158 823-827. (doi:10.1530/EJE-07-0877)
9. Williams I, Ankrett VO, Lazarus JH & Volpe R. Aetiology of hyperthyroidism in Canada and Wales. Journal of Epidemiology and Community Health 1983 37245-248. (doi:10.1136/jech.37.3.245)
10. Furszyfer J, Kurland LT, McConahey WM & Elveback LR. Graves' disease in Olmsted County, Minnesota, 1935 through 1967. Mayo Clinic Proceedings 1970 45 636-644.
11. Iversen K. Thyrotoxicosis in aged individuals. Journal of Gerontology 1953 8 65-69. (doi:10.1093/geronj/8.1.65)
12. Lavard L, Ranlov I, Perrild H, Andersen O & Jacobsen BB. Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study. European Journal of Endocrinology 1994 130 565-568. (doi:10.1530/eje.0.1300565)
13. Thjodleifsson B. A study of Graves' disease in Iceland. Acta Medica Scandinavica 1975 198 309-314. (doi:10.1111/j.0954-6820.1975.tb19546.x)
14. Berglund J, Christensen SB & Hallengren B. Total and age-specific incidence of Graves' thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmo 1970-74. Journal of Internal Medicine 1990 227 137-141. (doi:10.1111/j.1365-2796.1990.tb00132.x)
15. Kalk WJ & Kalk J. Incidence and causes of hyperthyroidism in blacks. South African Medical Journal 1989 75 114-117. (Pubitemid 19099203)
16. Reinwein D, Benker G, Konig MP, Pinchera A, Schatz H & Schleusener A. The different types of hyperthyroidism in Europe. Results of a prospective survey of 924 patients. Journal of Endocrinological Investigation 1988 11 193-200.
17. Thommesen N, Nirell I & Kristensen HP. Material on hyperthyroidism from a five-year period in a central hospital. Ugeskrift for Laeger 1971 133 1663-1669.
18. Bulfoni A. Epidemiological assessment of thyrotoxicosis in a hospitalized population. Minerva Medica 1986 77 815-818. (Pubitemid 16080806)
19. Carle A, Laurberg P, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB & Jorgensen T. Mainly the younger hypothyroid patients are referred to hospital - evidence for referral bias. Journal of Clinical Epidemiology 2009 62 446-451. (doi:10.1016/j.jclinepi.2008.06.016)
20. Laurberg P, Jorgensen T, Perrild H, Ovesen L, Knudsen N, Pedersen IB, Rasmussen LB, Carle A & Vejbjerg P. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. European Journal of Endocrinology 2006 155 219-228. (doi:10.1530/eje.1.02210)
21. BulowPedersen I, Knudsen N, Jorgensen T, Perrild H, Ovesen L & Laurberg P. Large differences in incidences of overt hyperand hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. Journal of Clinical Endocrinology and Metabolism 2002 87 4462-4469. (doi:10.1210/jc.2002-020750)
22. Rasmussen LB, Ovesen L, Bulow I, Jorgensen T, Knudsen N, Laurberg P & Pertild H. Dietary iodine intake and urinary iodine excretion in a Danish population: effect of geography, supplements and food choice. British Journal of Nutrition 2002 87 61-69. (doi:10.1079/BJN2001474)
23. Statistics Denmark, 2006. Available from http://www.danmarksstatistik.dk (accessed 26-1-2011), 2005.
24. Carle A. Subtypes of hypothyrodism, PhD Thesis 2006. Faculty of Health Sciences, University of Aarhus, Denmark.
25. Pedersen IB, Laurberg P, Arnfred T, Knudsen N, Jorgensen T, Perrild H & Ovesen L. Surveillance of disease frequency in a population by linkage to diagnostic laboratory databases. A system for monitoring the incidences of hyper- and hypothyroidism as part of the Danish iodine supplementation program. Computer Methods and Programs in Biomedicine 2002 67 209-216. (doi:10.1016/S0169-2607(01)00125-0)
26. Pedersen IB. On the importance of small differences in iodine intake for thyroid function. PhD Thesis 2002. Faculty of Health Sciences, University of Aarhus, Denmark.
27. Carle A, Laurberg P, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB & Jorgensen T. Epidemiology of subtypes of hypothyroidism in Denmark. European Journal of Endocrinology 2006 154 21-28. (doi:10.1530/eje.1. 02068)
28. Pedersen IB, Knudsen N, Perrild H, Ovesen L & Laurberg P. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clinical Endocrinology 2001 55 381-390. (doi:10.1046/j.1365- 2265.2001.01347.x)
29. Amico JA, Richardson V, Alpert B & Klein I. Clinical and chemical assessment of thyroid function during therapy with amiodarone. Archives of Internal Medicine 1984 144 487-490. (doi:10.1001/archinte.144.3.487)
30. Chen J & Shao J. Jackknife variance estimation for nearestneighbour imputation. Journal of the American Statistical Association 2001 96 260-269. (doi:10.1198/016214501750332839)
31. Rothman KJ & Greenland S. Modern Epidemiology, 2nd edn, pp 253-279. Philadelphia, PA: Lippincott Williams & Wilkins, 1998.
32. Kirkwood BR. The Poisson Distribution. In Essentials of Medical Statistics. 1st edn, pp 124-130. Oxford: Blackwell Scientific Publications, 1988.
33. Mogensen EF & Green A. The epidemiology of thyrotoxicosis in Denmark. Incidence and geographical variation in the Funen region 1972-1974. Acta Medica Scandinavica 1980 208 183-186. (doi:10.1111/j.0954-6820.1980.tb01174.x)
34. Johannessen AC. Atypical thyrotoxicosis. Ugeskrift for Laeger 1984 146 2767-2769.
35. Iversen E. Temporary Rise if the Frequency of Thyreotoxicosis in Denmark 1941-1945. Doctoral dissertation, pp 1-244, University of Copenhagen, Denmark: Rosenkilde & Bagger 1948.
36. Barker DJ & Phillips DI. Current incidence of thyrotoxicosis and past prevalence of goitre in 12 British towns. Lancet 1984 2 567-570. (doi:10.1016/S0140-6736(84)90776-1)
37. Haraldsson A, Gudmundsson ST, Larusson G & Sigurdsson G. Thyrotoxicosis in Iceland 1980-1982. An epidemiological survey. Acta Medica Scandinavica 1985 217 253-258. (doi:10.1111/j.0954-6820.1985.tb02691.x)
38. Brownlie BE & Wells JE. The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in north Canterbury, 1983-1985. Clinical Endocrinology 1990 33 249-259. (doi:10.1111/j.1365-2265.1990.tb00489. x)
39. Berglund J, Ericsson UB & Hallengren B. Increased incidence of thyrotoxicosis in Malmo during the years 1988-1990 as compared to the years 1970-1974. Journal of Internal Medicine 1996 239 57-62. (doi:10.1046/j.1365- 2796.1996.415757000.x)
40. Lundgren E & Borup Christensen S. Fallande incidens av thyreotocixos i Jämtland län under perioden 1975-1984 (abstract). Hygiea 1987 96 154.
41. Huang Q, Jin R & Zou D. Study on the effects of increased iodized salt intake on the incidence of thyroid diseases. Zhonghua Liu Xing Bing Xue Za Zhi 2001 22 455-458.
42. Flynn RW, MacDonald TM, Morris AD, Jung RT & Leese GP. The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population. Journal of Clinical Endocrinology and Metabolism 2004 89 3879-3884. (doi:10.1210/jc.2003-032089)
43. Riccabona G, Bauer H, Mathie F & Scholz K. Epidemiology and treatment of thyrotoxicosis in an endemic goitre district. Wiener Klinische Wochenschrift 1972 84 360-363.
44. Stewart JC & Vidor GI. Thyrotoxicosis induced by iodine contamination of food - a common unrecognised condition? BMJ 1976 1 372-375. (doi:10.1136/bmj.1.6006.372)
45. Krohn K, Wohlgemuth S, Gerber H & Paschke R. Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations. Journal of Pathology 2000 192 37-42. (doi:10.1002/1096- 9896(2000)9999:9999〈::AID-PATH650〉3.0.CO;2-3)
46. Todd CH, Allain T, Gomo ZA, Hasler JA, Ndiweni M & Oken E. Increase in thyrotoxicosis associated with iodine supplements in Zimbabwe. Lancet 1995 346 1563-1564. (doi:10.1016/S0140-6736(95)92095-1)
47. Hegedus L, Hansen JE, Veiergang D & Karstrup S. Thyroid size and goitre frequency in hyperthyroidism. Danish Medical Bulletin 1987 34 121-123.
48. Laurberg P, Pedersen KM, Vestergaard P & Vestergaard H. Hyperfunctioning thyroid nodules. Thyroidology 1991 3 1-6.
49. Pedersen KM, Laurberg P, Nohr S, Jorgensen A & Andersen S. Iodine in drinking water varies by more than 100-fold in Denmark. Importance for iodine content of infant formulas. European Journal of Endocrinology 1999 140 400-403. (doi:10.1530/eje.0.1400400)
50. Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M, Pacchiarotti A, Aronin N, Macchia E & Haffajee C. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Annals of Internal Medicine 1984 101 28-34. (Pubitemid 14088063)
51. Wallaschofski H, Orda C, Georgi P, Miehle K & Paschke R. Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter. Hormone Metabolic Research 2001 33 504-507. (doi:10.1055/s-2001-16945)